SureTrader Nadex Advertisement
Home > Boards > US Listed > Medical - Drugs >

Egalet Corporation (EGLT)

EGLT RSS Feed
Add EGLT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 2/24/2017 12:41:51 PM - Followers: 35 - Board type: Free - Posts Today: 0

Egalet Corporation 460 East Swedesford Road Suite 1050 Wayne, PA 19087 United States - Map Phone: 610-833-4200 Website: http://www.egalet.com Egalet Corporation, a specialty pharmaceutical company, is engaged in developing planning to commercialize proprietary, abuse-deterrent pharmaceutical products for the treatment of pain and other indications. It develops various clinical-stage opioid-based product candidates through its technology platform in tablet form that are specifically designed to deter abuse by physical and chemical manipulation while also providing tailored release of the active pharmaceutical ingredient. The company’s product candidates include Egalet-001 and Egalet-002 that are abuse-deterrent, extended-release, oral formulations for the treatment of moderate and severe pain. It is also developing a portfolio of preclinical abuse-deterrent product candidates for the treatment of pain and other conditions. The company was founded in 2010 and is headquartered Wayne, Pennsylvania.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EGLT
Current Price
Volume:
Bid Ask Day's Range
SureTrader
EGLT News: Egalet to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2016 Financial Results on March 9, 2017 02/23/2017 06:02:00 AM
EGLT News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 11:40:19 AM
EGLT News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 11:20:51 AM
EGLT News: Amended Statement of Ownership (sc 13g/a) 02/13/2017 12:03:39 PM
EGLT News: Amended Statement of Ownership (sc 13g/a) 02/09/2017 04:39:52 PM
PostSubject
#294   I got a response from IR they are Tekterra 02/24/17 12:41:51 PM
#293   Even though the sales force is small. Aloha922 02/23/17 09:21:45 AM
#292   The idea is that if you get a Tekterra 02/21/17 02:22:41 PM
#291   Why is the market not giving any credit diddobuyer 02/21/17 11:17:05 AM
#290   I have no idea!! Earnings? To show Aloha922 02/15/17 06:14:18 AM
#289   What news are we expecting, I haven't been Tekterra 02/14/17 03:58:22 PM
#288   Positive news ahead and we spike 30-50%+ Aetoss 02/14/17 11:21:39 AM
#287   I think they are lucky to be the Tekterra 02/13/17 11:48:56 AM
#286   There's a huge short position here (60%+). ksviking12 02/13/17 08:46:05 AM
#285   I completely agree with you.....but it seems like Aloha922 02/13/17 08:06:58 AM
#284   That is bad, but it is also good. ksviking12 02/13/17 07:56:57 AM
#283   Whats bad about it, is the company with Aloha922 02/13/17 07:19:21 AM
#282   So the understanding was that they didn't get Tekterra 02/09/17 12:08:19 PM
#281   SC 13G filed by Index Venture Associates III LAKERMAN 02/08/17 03:57:28 PM
#280   the stock is 4.50 going nowhere diddobuyer 02/07/17 02:53:09 PM
#279   the stock is 4.50 going nowhere diddobuyer 02/07/17 02:53:09 PM
#278   I just Found it on my Scanner... Lots europtiger 02/07/17 06:11:09 AM
#277   Good reads on EGLT... ksviking12 02/04/17 11:19:23 AM
#276   Another biotech terd skidding into the abyss diddobuyer 01/27/17 12:27:15 PM
#275   Thank you…..no kidding these small bios are tricky. girlfriend 01/26/17 02:31:58 PM
#274   I agree with you that timing the buying AquaFinance 01/26/17 02:19:00 PM
#273   Thanks. I understand all that but shorts girlfriend 01/26/17 01:57:14 PM
#272   As days to cover is 4.0 , it measures AquaFinance 01/26/17 01:47:56 PM
#271   What would be the catalyst for a major girlfriend 01/26/17 12:46:10 PM
#270   Major ShortSqueeze comin' AquaFinance 01/26/17 12:42:11 PM
#269   Aloha922: I gave up on the FDA bbotcs 01/24/17 03:52:31 PM
#268   EGLT must of thought they could get around Aloha922 01/24/17 06:48:16 AM
#267   Who gave MorphaBond labeling exclusivity? Was it bbotcs 01/23/17 11:56:47 PM
#266   FDA confirms Egalet's story. WeeZuhl 01/13/17 09:14:04 PM
#265   Of course the vulture law firms start their B.S.!!! Aloha922 01/13/17 08:05:48 AM
#264   ksviking12: I hear U. My problem bbotcs 01/12/17 11:36:31 AM
#263   60% short interest on what looks to be ksviking12 01/12/17 09:51:54 AM
#262   Warning: I lost quite a few dollars bbotcs 01/11/17 04:34:17 PM
#261   after. It was linked in Bret Jensen's SA article. realfast95 01/11/17 04:30:53 PM
#260   Was that after the FDA Bullshit or before. diddobuyer 01/11/17 04:26:31 PM
#259   1/11/2017 JMP Securities Reiterated Rating Outperform $15.00 realfast95 01/11/17 11:00:12 AM
#258   Biotech Forum Daily Digest: Keytruda Continues To Power realfast95 01/11/17 10:31:03 AM
#257   Egalet Corp Receives a Buy from Cantor Fitzgerald realfast95 01/11/17 10:29:18 AM
#256   realfast95: Thank U for the real fast response! bbotcs 01/10/17 03:17:35 PM
#255   morphabond's product isn't available for sale yet. realfast95 01/10/17 03:13:05 PM
#254   Next drug. Won't the abuse-deterrent version of bbotcs 01/10/17 03:04:04 PM
#253   Hi, I'm new to the board and to bbotcs 01/10/17 03:02:56 PM
#252   Is there a competing product or products? Giovanni 01/10/17 02:57:01 PM
#251   they already have two products and sales team realfast95 01/10/17 11:25:44 AM
#250   Now comes the hard part, they have to Giovanni 01/10/17 11:22:21 AM
#249   no one can win the label war. No realfast95 01/10/17 10:40:09 AM
#248   In my opinion they did not deny them Aloha922 01/10/17 10:33:00 AM
#247   Impact of Exclusivity on Approval of Arymo ER realfast95 01/10/17 10:07:44 AM
#246   IF it gets anywhere below $6 I will add. girlfriend 01/10/17 10:03:00 AM
#245   EGLT – Gabelli & Co. cuts to a realfast95 01/10/17 10:01:50 AM
PostSubject